StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CPTP.TA$43.60+0.23%
Fair $43.60+0.0%

CPTP.TA

Capital Point Ltd.

Financial Services / Asset ManagementTel Aviv

$43.60

+0.10 (+0.23%)

Fairly Valued+0.0%Fair Value $43.60Fund rank 25/100 · Data gapFallback financials|
SA 35/D
F-Score: 5/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · CPTP.TALocal privado en este navegador · Capital Point Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$58M

P/E

8.7x

↓

EV/EBITDA

389.3x

↑

ROE

5.9%

↓

Gross Margin

-209.0%

↓

Debt/Equity

0.20

↓
52-Week Range$44
$1$62

TradingView lightweight chart

CPTP.TA price, volumen y niveles de valoración

Último $43.50Periodo -97.2%
Fair value: $43.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-12.6%

FCF CAGR

—

FCF margin

-343.5%

FCF / Net income

-0.86x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.8M · net income $7.3M · FCF $-6.3M

2022-FY → 2025-FY

Gross margin

-209.0%-107.6% pts

Operating margin

795.1%+976.8% pts

Net margin

399.5%+1519.7% pts

FCF margin

-343.5%+74.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.8M$1.8M$969000.00$242000.00$2.7M
Net Income$7.3M$7.3M$-23.9M$1.7M$-30.6M
EBITDA$15.0M$15.0M$15.4M$20.4M$-4.4M
EPS——-0.180.01-0.24
Gross Margin-209.0%-209.0%-475.6%-2248.3%-101.4%
Operating Margin795.1%795.1%1532.1%8217.4%-181.7%
Net Margin399.5%399.5%-2466.8%707.0%-1120.2%
Balance Sheet
Debt/Equity0.200.200.210.170.17
Current Ratio2.822.82———
Cash Flow
Free Cash Flow$-6.3M$-6.3M$-6.7M$-6.3M$-11.4M
Returns
ROE5.9%5.9%-20.4%1.2%-22.3%
Valuation
P/E8.728.72—6550.00—
EV/EBITDA389.33389.33519.01429.03—
P/B46.8746.8768.3862.2860.17
Growth & Yield
Revenue Growth88.0%88.0%300.4%-91.1%—
EPS Growth——-1900.0%104.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -9.2%

Total return

-9.2%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.18 → n/d

Residual

-9.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-9.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.